Coloplast A/S (OTCMKTS:CLPBF – Get Free Report) is anticipated to release its results before the market opens on Tuesday, November 3rd. Analysts expect Coloplast A/S to post earnings of $0.8930 per share and revenue of $1.12 billion for the quarter.
Coloplast A/S Price Performance
Shares of Coloplast A/S stock opened at $70.02 on Tuesday. Coloplast A/S has a 52-week low of $56.81 and a 52-week high of $95.43. The company has a fifty day moving average of $65.85 and a 200-day moving average of $67.73.
About Coloplast A/S
Coloplast A/S is a Denmark-based medical technology company that develops and manufactures products and services for people with intimate healthcare needs. Its principal business areas include ostomy care, continence care, wound and skin care, and interventional urology.
The company’s product portfolio includes ostomy bags and accessories, intermittent and indwelling catheters, bowel management systems, urological devices, and wound care products. Its brands include SenSura, SpeediCath, Peristeen, and Biatain, among others.
Read More
- Five stocks we like better than Coloplast A/S
- A Solid Margin Story Means the Sell-Off in DECK May Be Overdone
- Verizon’s Q3 Results Show Why SpaceX’s Spectrum Grab Isn’t a Major Threat
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
